1. A novel blood-brain barrier delivery platform powered by AI-optimized VHH nanobodies with dual TfR & CD98hc targeting,
which doubles brain uptake and sustains high cerebral drug concentration for over 14 days.
2. This modular platform flexibly loads siRNA, small molecules and therapeutic proteins, features cross-reactivity across
human, mouse and cynomolgus monkey, holds independent global patents,
and iteratively develops drugs to treat CNS disorders including Alzheimer's, Parkinson's and brain tumors.